Hayley Evans: Variability in Perioperative TXA Practice Despite Strong Evidence
Hayley Evans, Deputy Director at the NIHR Blood and Transplant Research Unit in Data Driven Transfusion Practice, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in BJHaem, adding:
“One of the interesting areas of perioperative research is not simply what works, but why evidence based practice is adopted inconsistently in real world clinical settings.
Our new paper in the British Journal of Haematology explores this through perioperative tranexamic acid (TXA) use across UK surgical practice.
Despite strong evidence supporting TXA, clinicians still vary considerably in how and when they use it.
Using a behavioural science framework, we explored some of the cognitive, cultural and organisational factors behind that variation.
Implementation is rarely just about evidence alone.”
Title: Survey on perioperative tranexamic acid use
Authors: Louise H. Strickland, Hayley G. Evans, Olivia C. Robinson, Samantha Warnakulasuriya, Robbie Foy, Simon J. Stanworth
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn RuksakulpiwatÖ‰ A New Milestone in the Development of the Stroke Risk Screening Scales